{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:16:13Z","timestamp":1792782973809,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272045"],"award-info":[{"award-number":["82272045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Foundation of the National Clinical Research Center for Geriatric Diseases","award":["2020LNJJ01"],"award-info":[{"award-number":["2020LNJJ01"]}],"id":[{"id":"https:\/\/ror.org\/03ddkvp86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key Program of Ministry of Industry and Information Technology of China","award":["CEIEC-2022-ZM02-0219"],"award-info":[{"award-number":["CEIEC-2022-ZM02-0219"]}],"id":[{"id":"https:\/\/ror.org\/0385nmy68","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30936"],"award-info":[{"award-number":["2022JJ30936"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00259-025-07350-8","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T22:57:54Z","timestamp":1748818674000},"page":"128-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Multi-Organ metabolic profiling with [18F]F-FDG PET\/CT predicts pathological response to neoadjuvant immunochemotherapy in resectable NSCLC"],"prefix":"10.1007","volume":"53","author":[{"given":"Qiaoke","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenna","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0998-8943","authenticated-orcid":false,"given":"Shuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"7350_CR1","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung Cancer. N Engl J Med. 2022;386:1973\u201385. https:\/\/doi.org\/10.1056\/NEJMoa2202170.","journal-title":"N Engl J Med"},{"key":"7350_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamaoncol.2024.0057","volume":"10","author":"M Sorin","year":"2024","unstructured":"Sorin M, Prosty C, Ghaleb L, Nie K, Katergi K, Shahzad MH, et al. Neoadjuvant chemoimmunotherapy for NSCLC: A systematic review and Meta-Analysis. JAMA Oncol. 2024;10:621\u201333. https:\/\/doi.org\/10.1001\/jamaoncol.2024.0057.","journal-title":"JAMA Oncol"},{"key":"7350_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa2302983","volume":"389","author":"H Wakelee","year":"2023","unstructured":"Wakelee H, Liberman M, Kato T, Tsuboi M, Lee S-H, Gao S, et al. Perioperative pembrolizumab for Early-Stage Non-Small-Cell lung Cancer. N Engl J Med. 2023;389:491\u2013503. https:\/\/doi.org\/10.1056\/NEJMoa2302983.","journal-title":"N Engl J Med"},{"key":"7350_CR4","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jtho.2020.05.020","volume":"15","author":"D Uprety","year":"2020","unstructured":"Uprety D, Mandrekar SJ, Wigle D, Roden AC, Adjei AA. Neoadjuvant immunotherapy for NSCLC: current concepts and future approaches. J Thorac Oncol. 2020;15:1281\u201397. https:\/\/doi.org\/10.1016\/j.jtho.2020.05.020.","journal-title":"J Thorac Oncol"},{"key":"7350_CR5","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1097\/JS9.0000000000000496","volume":"109","author":"Y Chen","year":"2023","unstructured":"Chen Y, Qin J, Wu Y, Lin Q, Wang J, Zhang W, et al. Does major pathological response after neoadjuvant immunotherapy in resectable nonsmall-cell lung cancers predict prognosis? A systematic review and meta-analysis. Int J Surg. 2023;109:2794\u2013807. https:\/\/doi.org\/10.1097\/JS9.0000000000000496.","journal-title":"Int J Surg"},{"key":"7350_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","volume":"6","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brahmer JR, Callahan MK, Flores-Ch\u00e1vez A, Keegan N, Khamashta MA, et al. Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers. 2020;6:38. https:\/\/doi.org\/10.1038\/s41572-020-0160-6.","journal-title":"Nat Rev Dis Primers"},{"key":"7350_CR7","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","volume":"18","author":"L Seymour","year":"2017","unstructured":"Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017;18:e143\u201352. https:\/\/doi.org\/10.1016\/S1470-2045(17)30074-8.","journal-title":"Lancet Oncol"},{"key":"7350_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1148\/radiol.2016142043","volume":"280","author":"JH O","year":"2016","unstructured":"O JH, Lodge MA, Wahl RL, Practical PERCIST. A simplified guide to PET response criteria in solid tumors 1.0. Radiology. 2016;280:576\u201384. https:\/\/doi.org\/10.1148\/radiol.2016142043.","journal-title":"Radiology"},{"key":"7350_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00259-018-4171-4","volume":"46","author":"N Aide","year":"2019","unstructured":"Aide N, Hicks RJ, Le Tourneau C, Lheureux S, Fanti S, Lopci E. FDG PET\/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature. Eur J Nucl Med Mol Imaging. 2019;46:238\u201350. https:\/\/doi.org\/10.1007\/s00259-018-4171-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7350_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41392-023-01700-4","volume":"8","author":"S-Y Liu","year":"2023","unstructured":"Liu S-Y, Dong S, Yang X-N, Liao R-Q, Jiang B-Y, Wang Q, et al. Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study. Signal Transduct Target Ther. 2023;8:442. https:\/\/doi.org\/10.1038\/s41392-023-01700-4.","journal-title":"Signal Transduct Target Ther"},{"key":"7350_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","volume":"30","author":"TA Chan","year":"2019","unstructured":"Chan TA, Yarchoan M, Jaffee E, Swanton C, Quezada SA, Stenzinger A, et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol. 2019;30:44\u201356. https:\/\/doi.org\/10.1093\/annonc\/mdy495.","journal-title":"Ann Oncol"},{"key":"7350_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.trecan.2024.04.004","volume":"10","author":"C Abbosh","year":"2024","unstructured":"Abbosh C, Hodgson D, Doherty GJ, Gale D, Black JRM, Horn L, et al. Implementing Circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer. Trends Cancer. 2024;10:643\u201354. https:\/\/doi.org\/10.1016\/j.trecan.2024.04.004.","journal-title":"Trends Cancer"},{"key":"7350_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ygyno.2020.08.001","volume":"159","author":"EA De Jaeghere","year":"2020","unstructured":"De Jaeghere EA, Laloo F, Lippens L, Van Bockstal M, De Man K, Naert E, et al. Splenic 18F-FDG uptake on baseline PET\/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer. Gynecol Oncol. 2020;159:335\u201343. https:\/\/doi.org\/10.1016\/j.ygyno.2020.08.001.","journal-title":"Gynecol Oncol"},{"key":"7350_CR14","doi-asserted-by":"publisher","first-page":"e12859","DOI":"10.1097\/MD.0000000000012859","volume":"97","author":"SY Jeong","year":"2018","unstructured":"Jeong SY, Kim S-J, Pak K, Lee S-W, Ahn B-C, Lee J. Prognostic value of 18F-fluorodeoxyglucose bone marrow uptake in patients with solid tumors: A meta-analysis. Med (Baltim). 2018;97:e12859. https:\/\/doi.org\/10.1097\/MD.0000000000012859.","journal-title":"Med (Baltim)"},{"key":"7350_CR15","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1007\/s00259-023-06327-9","volume":"50","author":"C Sachpekidis","year":"2023","unstructured":"Sachpekidis C, Stein-Thoeringer CK, Kopp-Schneider A, Weru V, Dimitrakopoulou-Strauss A, Hassel JC. Can physiologic colonic [18F]FDG uptake in PET\/CT imaging predict response to immunotherapy in metastatic melanoma? Eur J Nucl Med Mol Imaging. 2023;50:3709\u201322. https:\/\/doi.org\/10.1007\/s00259-023-06327-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7350_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lungcan.2021.06.024","volume":"159","author":"R-D Seban","year":"2021","unstructured":"Seban R-D, Assi\u00e9 J-B, Giroux-Leprieur E, Massiani M-A, Bonardel G, Chouaid C, et al. Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET\/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy. Lung Cancer. 2021;159:45\u201355. https:\/\/doi.org\/10.1016\/j.lungcan.2021.06.024.","journal-title":"Lung Cancer"},{"key":"7350_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cytogfr.2018.01.002","volume":"39","author":"S Naseem","year":"2018","unstructured":"Naseem S, Hussain T, Manzoor S. Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies. Cytokine Growth Factor Rev. 2018;39:36\u201345. https:\/\/doi.org\/10.1016\/j.cytogfr.2018.01.002.","journal-title":"Cytokine Growth Factor Rev"},{"key":"7350_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1007\/s00259-020-05081-6","volume":"48","author":"L Cvetkovic","year":"2021","unstructured":"Cvetkovic L, R\u00e9gis C, Richard C, Derosa L, Leblond A, Malo J, et al. Physiologic colonic uptake of 18F-FDG on PET\/CT is associated with clinical response and gut Microbiome composition in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Eur J Nucl Med Mol Imaging. 2021;48:1550\u20139. https:\/\/doi.org\/10.1007\/s00259-020-05081-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7350_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/cac2.12153","volume":"41","author":"J Kang","year":"2021","unstructured":"Kang J, Zhang C, Zhong W-Z. Neoadjuvant immunotherapy for non-small cell lung cancer: state of the Art. Cancer Commun (Lond). 2021;41:287\u2013302. https:\/\/doi.org\/10.1002\/cac2.12153.","journal-title":"Cancer Commun (Lond)"},{"key":"7350_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","volume":"35","author":"E Gontier","year":"2008","unstructured":"Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, et al. High and typical 18F-FDG bowel uptake in patients treated with Metformin. Eur J Nucl Med Mol Imaging. 2008;35:95\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7350_CR21","doi-asserted-by":"publisher","first-page":"e230024","DOI":"10.1148\/ryai.230024","volume":"5","author":"J Wasserthal","year":"2023","unstructured":"Wasserthal J, Breit H-C, Meyer MT, Pradella M, Hinck D, Sauter AW, et al. TotalSegmentator: robust segmentation of 104 anatomic structures in CT images. Radiol Artif Intell. 2023;5:e230024. https:\/\/doi.org\/10.1148\/ryai.230024.","journal-title":"Radiol Artif Intell"},{"key":"7350_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41592-020-01008-z","volume":"18","author":"F Isensee","year":"2021","unstructured":"Isensee F, Jaeger PF, Kohl SAA, Petersen J, Maier-Hein KH. nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. 2021;18:203\u201311. https:\/\/doi.org\/10.1038\/s41592-020-01008-z.","journal-title":"Nat Methods"},{"key":"7350_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","volume":"15","author":"WD Travis","year":"2020","unstructured":"Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, et al. IASLC multidisciplinary recommendations for pathologic assessment of lung Cancer resection specimens after neoadjuvant therapy. J Thorac Oncol. 2020;15:709\u201340. https:\/\/doi.org\/10.1016\/j.jtho.2020.01.005.","journal-title":"J Thorac Oncol"},{"key":"7350_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L, Random, Forests. Mach Learn. 2001;45:5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324.","journal-title":"Mach Learn"},{"key":"7350_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the Lasso. J Royal Stat Soc Ser B (Methodological). 1996;58:267\u201388.","journal-title":"J Royal Stat Soc Ser B (Methodological)"},{"key":"7350_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/bioinformatics\/btab659","volume":"38","author":"F Motamedi","year":"2022","unstructured":"Motamedi F, P\u00e9rez-S\u00e1nchez H, Mehridehnavi A, Fassihi A, Ghasemi F. Accelerating big data analysis through LASSO-random forest algorithm in QSAR studies. Bioinformatics. 2022;38:469\u201375. https:\/\/doi.org\/10.1093\/bioinformatics\/btab659.","journal-title":"Bioinformatics"},{"key":"7350_CR27","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.7150\/jca.95501","volume":"15","author":"J Lin","year":"2024","unstructured":"Lin J, Cai B, Lin Q, Lin X, Wang B, Chen X. TLE4 downregulation identified by WGCNA and machine learning algorithm promotes papillary thyroid carcinoma progression via activating JAK\/STAT pathway. J Cancer. 2024;15:4759\u201376. https:\/\/doi.org\/10.7150\/jca.95501.","journal-title":"J Cancer"},{"key":"7350_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2967\/jnumed.115.167684","volume":"57","author":"IA Burger","year":"2016","unstructured":"Burger IA, Casanova R, Steiger S, Husmann L, Stolzmann P, Huellner MW, et al. 18F-FDG PET\/CT of Non-Small cell lung carcinoma under neoadjuvant chemotherapy: Background-Based Adaptive-Volume metrics outperform TLG and MTV in predicting histopathologic response. J Nucl Med. 2016;57:849\u201354. https:\/\/doi.org\/10.2967\/jnumed.115.167684.","journal-title":"J Nucl Med"},{"key":"7350_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00259-020-04711-3","volume":"47","author":"X Tao","year":"2020","unstructured":"Tao X, Li N, Wu N, He J, Ying J, Gao S, et al. The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 Blockade in resectable non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2020;47:1209\u201319. https:\/\/doi.org\/10.1007\/s00259-020-04711-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7350_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lungcan.2023.02.001","volume":"178","author":"F Zhuang","year":"2023","unstructured":"Zhuang F, Haoran E, Huang J, Wu J, Xu L, Zhang L, et al. Utility of 18F-FDG PET\/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer. Lung Cancer. 2023;178:20\u20137. https:\/\/doi.org\/10.1016\/j.lungcan.2023.02.001.","journal-title":"Lung Cancer"},{"key":"7350_CR31","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1007\/s00259-016-3425-2","volume":"43","author":"E Lopci","year":"2016","unstructured":"Lopci E, Toschi L, Grizzi F, Rahal D, Olivari L, Castino GF, et al. Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery. Eur J Nucl Med Mol Imaging. 2016;43:1954\u201361. https:\/\/doi.org\/10.1007\/s00259-016-3425-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7350_CR32","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJM, Robert L, et al. PD-1 Blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014;515:568\u201371. https:\/\/doi.org\/10.1038\/nature13954.","journal-title":"Nature"},{"key":"7350_CR33","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/bjc.2014.90","volume":"110","author":"CSD Roxburgh","year":"2014","unstructured":"Roxburgh CSD, McMillan DC. Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer. 2014;110:1409\u201312. https:\/\/doi.org\/10.1038\/bjc.2014.90.","journal-title":"Br J Cancer"},{"key":"7350_CR34","first-page":"559","volume":"47","author":"S Pr\u00e9vost","year":"2006","unstructured":"Pr\u00e9vost S, Boucher L, Lariv\u00e9e P, Boileau R, B\u00e9nard F. Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer. J Nucl Med. 2006;47:559\u201365.","journal-title":"J Nucl Med"},{"key":"7350_CR35","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cllc.2016.07.001","volume":"18","author":"JW Lee","year":"2017","unstructured":"Lee JW, Na JO, Kang D-Y, Lee SY, Lee SM. Prognostic significance of FDG uptake of bone marrow on PET\/CT in patients with Non-Small-Cell lung Cancer after curative surgical resection. Clin Lung Cancer. 2017;18:198\u2013206. https:\/\/doi.org\/10.1016\/j.cllc.2016.07.001.","journal-title":"Clin Lung Cancer"},{"key":"7350_CR36","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1007\/s00330-016-4568-z","volume":"27","author":"JW Lee","year":"2017","unstructured":"Lee JW, Seo KH, Kim E-S, Lee SM. The role of 18F-fluorodeoxyglucose uptake of bone marrow on PET\/CT in predicting clinical outcomes in non-small cell lung cancer patients treated with chemoradiotherapy. Eur Radiol. 2017;27:1912\u201321. https:\/\/doi.org\/10.1007\/s00330-016-4568-z.","journal-title":"Eur Radiol"},{"key":"7350_CR37","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3892\/or.2011.1226","volume":"25","author":"GP Stathopoulos","year":"2011","unstructured":"Stathopoulos GP, Armakolas A, Tranga T, Marinou H, Stathopoulos J, Chandrinou H. Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancer. Oncol Rep. 2011;25:1541\u20134. https:\/\/doi.org\/10.3892\/or.2011.1226.","journal-title":"Oncol Rep"},{"key":"7350_CR38","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/s41598-021-81298-1","volume":"11","author":"K Shimura","year":"2021","unstructured":"Shimura K, Mabuchi S, Komura N, Yokoi E, Kozasa K, Sasano T, et al. Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer. Sci Rep. 2021;11:2257. https:\/\/doi.org\/10.1038\/s41598-021-81298-1.","journal-title":"Sci Rep"},{"key":"7350_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00259-007-0628-6","volume":"35","author":"C Van de Wiele","year":"2008","unstructured":"Van de Wiele C, VandeVyver F, Debruyne C, Philipp\u00e9 J, van Meerbeeck JP. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels. Eur J Nucl Med Mol Imaging. 2008;35:519\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7350_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","volume":"141","author":"X Yao","year":"2014","unstructured":"Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 2014;141:125\u201339. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.09.004.","journal-title":"Pharmacol Ther"},{"key":"7350_CR41","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.7150\/ijbs.70958","volume":"18","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Guo S, Deng J, Shen J, Du F, Wu X, et al. VEGF\/VEGFR-Targeted therapy and immunotherapy in Non-small cell lung cancer: targeting the tumor microenvironment. Int J Biol Sci. 2022;18:3845\u201358. https:\/\/doi.org\/10.7150\/ijbs.70958.","journal-title":"Int J Biol Sci"},{"key":"7350_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2009.11.008","volume":"21","author":"B Bierie","year":"2010","unstructured":"Bierie B, Moses HL. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev. 2010;21:49\u201359. https:\/\/doi.org\/10.1016\/j.cytogfr.2009.11.008.","journal-title":"Cytokine Growth Factor Rev"},{"key":"7350_CR43","doi-asserted-by":"publisher","first-page":"101512","DOI":"10.1016\/j.smim.2021.101512","volume":"54","author":"KA Mouchemore","year":"2021","unstructured":"Mouchemore KA, Anderson RL. Immunomodulatory effects of G-CSF in cancer: therapeutic implications. Semin Immunol. 2021;54:101512. https:\/\/doi.org\/10.1016\/j.smim.2021.101512.","journal-title":"Semin Immunol"},{"key":"7350_CR44","doi-asserted-by":"publisher","unstructured":"Ahn H, Song GJ, Lee M-S, Lee J-H, Jang S-H, Oh M-H, et al. Relationship of FDG uptake of the reticuloendothelial system with tumor immune microenvironment and prognosis in patients with gastric Cancer. Life (Basel). 2023;13. https:\/\/doi.org\/10.3390\/life13030771.","DOI":"10.3390\/life13030771"},{"key":"7350_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40644-024-00698-4","volume":"24","author":"JW Lee","year":"2024","unstructured":"Lee JW, Ahn H, Yoo ID, Hong S-P, Baek M-J, Kang DH, et al. Relationship of FDG PET\/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study. Cancer Imaging. 2024;24:53. https:\/\/doi.org\/10.1186\/s40644-024-00698-4.","journal-title":"Cancer Imaging"},{"key":"7350_CR46","doi-asserted-by":"publisher","unstructured":"Koulouridi A, Messaritakis I, Gouvas N, Tsiaoussis J, Souglakos J. Immunotherapy in solid tumors and gut microbiota: the Correlation-A special reference to colorectal Cancer. Cancers (Basel). 2020;13. https:\/\/doi.org\/10.3390\/cancers13010043.","DOI":"10.3390\/cancers13010043"},{"key":"7350_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, et al. Gut Microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359:91\u20137. https:\/\/doi.org\/10.1126\/science.aan3706.","journal-title":"Science"},{"key":"7350_CR48","doi-asserted-by":"publisher","first-page":"e0192747","DOI":"10.1371\/journal.pone.0192747","volume":"13","author":"B Boursi","year":"2018","unstructured":"Boursi B, Werner TJ, Gholami S, Houshmand S, Mamtani R, Lewis JD, et al. Functional imaging of the interaction between gut microbiota and the human host: A proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CT. PLoS ONE. 2018;13:e0192747. https:\/\/doi.org\/10.1371\/journal.pone.0192747.","journal-title":"PLoS ONE"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07350-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:05:49Z","timestamp":1764219949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07350-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7350"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07350-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board of Xiangya Hospital, Central South University and the requirement for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}